As of my last update in October 2023, there is no specific information available regarding a chemical substance with the name "INDEX NAME NOT YET ASSIGNED" and CAS number 2699607-86-6. This designation suggests that the substance may be newly synthesized, under investigation, or not yet fully characterized in the scientific literature. Typically, substances with unassigned index names may be in the early stages of research, and detailed properties such as molecular structure, reactivity, physical state, and potential applications may not be readily available. For accurate and updated information, it is advisable to consult chemical databases, scientific publications, or regulatory agencies that may provide insights into newly identified compounds. If this substance is of particular interest, monitoring ongoing research or contacting relevant chemical safety organizations may yield further details as they become available.

Tigecycline-d
9
is intended for use as an internal standard for the quantification of tigecycline  by GC- or LC-MS. Tigecycline is a broad-spectrum glycylcycline antibiotic that binds to the bacterial 30S ribosome, blocking the entry of transfer RNA, which halts protein synthesis and inhibits bacterial growth.
1
It is active against a panel of 1,924 European clinical bacterial isolates including
S. aureus
,
S. epidermidis
,
S. pneumoniae
,
E. faecalis
,
E. faecium
,
E. coli
,
K. pneumoniae
,
P. aeruginosa
, and
P. mirabilis
strains (MICs = <1-32 μg/ml).
2
In vivo
, tigecycline (6.25 mg/kg twice daily for 5 days) decreases levels of
C. difficile
cytotoxin activity and spore formation in cecum and colon in a mouse model of
C. difficile
infection.
3
Formulations containing tigecycline have been used in the treatment of a variety of bacterial infections.

INDEX NAME NOT YET ASSIGNED

2699607-86-6: As of my last update in October 2023, there is no specific information available regarding a chemical substance with the name "INDEX NAME NOT YET ASSIGNED" and CAS number 2699607-86-6. This designation suggests that the substance may be newly synthesized, under investigation, or not yet fully characterized in the scientific literature. Typically, substances with unassigned index names may be in the early stages of research, and detailed properties such as molecular structure, reactivity, physical state, and potential applications may not be readily available. For accurate and updated information, it is advisable to consult chemical databases, scientific publications, or regulatory agencies that may provide insights into newly identified compounds. If this substance is of particular interest, monitoring ongoing research or contacting relevant chemical safety organizations may yield further details as they become available.

Tigecycline-d9

Tigecycline-d9 is a deuterated compound of Tigecycline. Tigecycline has a CAS number of 220620-09-7. Tigecycline is a broad-spectrum glycylcycline antibiotic derived from tetracycline. Tigecycline binds to the 30S ribosomal subunit, thereby interfering with the binding of aminoacyl-tRNA to the mRNA-ribosome complex.

CAS 2699607-86-6

INDEX NAME NOT YET ASSIGNED

Tigecycline-d9

Ref: 4Z-T-109017

Tigecycline-d9

Ref: TM-TMID-0084